Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03712774

Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant or Definitive Chemoradiation in Patients With Esophageal Cancer

Status
Recruiting
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Ludwig-Maximilians - University of Munich · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Prospective observational study to evaluate the Quality of life based on standardized EORTC questionaires as well as toxicities, functional and oncological outcomes in patients treated with neoadjuvant or definitive chemoradiation for esophageal Cancer.

Detailed description

Prospective observational study to evaluate the Quality of life based in patients treated with neoadjuvant or definitive chemoradiation for esophageal Cancer. QoL will be evaluated by standardized EORTC questionaires. Acute and late toxicity will be assessed according to CTCAE 4.03. Outcome measures will include local Control, distant Control, freedom from Treatment failure and overall survival. Correlations are planned between Patient- and physician-assessed functional Outcome.

Conditions

Interventions

TypeNameDescription
OTHEREORTC QLQ C30standardized questionaire
OTHEREORTC QLQ OES-18standardized questionaire
OTHEREORTC OG-25standardized questionaire

Timeline

Start date
2018-10-12
Primary completion
2021-12-31
Completion
2026-12-31
First posted
2018-10-19
Last updated
2018-10-19

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03712774. Inclusion in this directory is not an endorsement.